CAD 0.14
(-6.67%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -24.9 Million USD | -4.11% |
2022 | -41.68 Million USD | -164.03% |
2021 | -38.03 Million USD | 218.84% |
2020 | -42.53 Million USD | -151.41% |
2019 | -16.91 Million USD | -198.19% |
2018 | 17.22 Million USD | 33.72% |
2017 | 12.71 Million USD | 954.34% |
2016 | 1.21 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -10.79 Million USD | -64.33% |
2024 Q1 | -4.01 Million USD | 4.42% |
2023 Q2 | -10.96 Million USD | -19.32% |
2023 FY | - USD | -4.11% |
2023 Q4 | -9.35 Million USD | -122.86% |
2023 Q3 | -4.19 Million USD | 61.72% |
2023 Q1 | -9.18 Million USD | 63.52% |
2022 Q1 | -6.66 Million USD | -109.7% |
2022 FY | - USD | -164.03% |
2022 Q4 | -25.18 Million USD | -553.16% |
2022 Q3 | 5.55 Million USD | 191.46% |
2022 Q2 | -6.07 Million USD | 8.82% |
2021 FY | - USD | 218.84% |
2021 Q1 | -6.87 Million USD | 28.61% |
2021 Q4 | 68.69 Million USD | 1311.12% |
2021 Q3 | -5.67 Million USD | -1.27% |
2021 Q2 | -5.6 Million USD | 18.55% |
2020 Q2 | -11.91 Million USD | -268.1% |
2020 Q1 | -3.23 Million USD | 86.49% |
2020 Q4 | -9.63 Million USD | 10.25% |
2020 FY | - USD | -151.41% |
2020 Q3 | -10.73 Million USD | 9.95% |
2019 Q2 | 3.41 Million USD | -14.76% |
2019 Q1 | 4 Million USD | -4.94% |
2019 FY | - USD | -198.19% |
2019 Q4 | -23.96 Million USD | -6630.34% |
2019 Q3 | -356 Thousand USD | -110.43% |
2018 Q2 | 5.33 Million USD | 19.53% |
2018 Q1 | 4.46 Million USD | 6.39% |
2018 Q3 | 3.21 Million USD | -39.74% |
2018 FY | - USD | 33.72% |
2018 Q4 | 4.21 Million USD | 30.94% |
2017 Q2 | 2.45 Million USD | 0.49% |
2017 FY | - USD | 954.34% |
2017 Q1 | 2.44 Million USD | 0.0% |
2017 Q4 | 4.19 Million USD | 17.69% |
2017 Q3 | 3.56 Million USD | 45.31% |
2016 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aurora Cannabis Inc. | 20.47 Million CAD | 221.637% |
Avicanna Inc. | -7.35 Million CAD | -238.578% |
Avant Brands Inc. | 4.83 Million CAD | 614.971% |
Cardiol Therapeutics Inc. | -27.87 Million CAD | 10.674% |
Crescita Therapeutics Inc. | 45 Thousand CAD | 55442.222% |
Knight Therapeutics Inc. | 40.89 Million CAD | 160.894% |
MediPharm Labs Corp. | -10.47 Million CAD | -137.679% |
OrganiGram Holdings Inc. | -207.61 Million CAD | 88.005% |
Canopy Growth Corporation | -312.82 Million CAD | 92.039% |
Willow Biosciences Inc. | -11.06 Million CAD | -125.151% |
Auxly Cannabis Group Inc. | -10.82 Million CAD | -130.06% |